EUVIMEDEUVIMED entdecken
Open Access

Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys

Daniel Ramírez-García iD, Jerónimo Perezalonso-Espinosa iD, Padme Nailea Méndez-Labra, Carlos A Fermín-Martínez iD, Juan Pablo Díaz-Sánchez iD, César Daniel Paz-Cabrera iD, Arsenio Vargas-Vázquez iD, Miriam Teresa López-Teros iD, David Flood, Jennifer Manne-Ghoeler iD, Neftali Eduardo Antonio-Villa, Goodarz Danaei iD und 2 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.044366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Daniel Ramírez-García und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Division, Instituto Nacional de Geriatría Mexico City Mexico. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Effective cardiovascular disease (CVD) risk management is essential for optimal diabetes care. Here, we estimated the prevalence and determinants of CVD risk factor control among individuals with diagnosed diabetes in Mexico.

Methods

We analyzed data from individuals ≥20 years with diagnosed diabetes from 2016 to 2023 Mexican National Health and Nutrition Surveys. We estimated the prevalence of glycemic, blood pressure, noncurrent smoking, low‐density lipoprotein cholesterol, and combined CVD risk factor control. We estimated use of blood pressure‐lowering, cholesterol‐lowering, and glucose‐lowering medication and explored determinants of control achievement using logistic regression.

Results

We analyzed data from 2916 participants, representing 43.2 million adults with diagnosed diabetes during 2016 to 2023. In 2023, glycemic control was 29% (95% CI, 21%–38%), blood pressure control 22.9% (95% CI, 14%–31%), and noncurrent smoking 89% (95% CI, 81%–96%). The prevalence of high or very‐high CVD risk using Systematic Coronary Risk Evaluation 2‐Diabetes increased from 59.8% (95% CI, 52.1%–67.0%) in 2016 to 68.4% (95% CI, 55.6%–78.9%) in 2023, representing ~5.1 million adults. Low‐density lipoprotein cholesterol control increased from 2.8% (95% CI, 1.2%–4.4%) in 2016 to 6.6% (95% CI, 1.9%–11.2%) in 2023 and statin use from 5.5% in 2016 to 63% in 2023. Combined risk factor control achievement was low due to suboptimal low‐density lipoprotein cholesterol control and was more likely achieved in women, younger individuals, and those with college education or living in states with higher socioeconomic position.

Conclusions

Despite increasing CVD risk during this period, glycemic and CVD risk factor management for adults with diabetes in Mexico remains suboptimal. Our findings suggest a need for strategies to improve CVD risk management to reduce diabetes‐related mortality and complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesDiabetes MellitusHumansFemaleMexicoMiddle AgedAdultMaleRetrospective StudiesPrevalenceHeart Disease Risk FactorsGlycemic ControlNutrition SurveysHypoglycemic AgentsRisk AssessmentRisk FactorsAgedBlood GlucoseYoung Adult

Stichwörter der Autor:innen

LDL‐C controlMexicoSCORE2‐Diabetesblood pressurediabetesglycemic control

Substanzen

Hypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Research Division, Instituto Nacional de Geriatría Mexico City Mexico.
  • Facultad de Medicina, Universidad Nacional Autónoma de México Mexico City Mexico.
  • Especialidad en Medicina Preventiva, Instituto Nacional de Salud Pública Mexico City Mexico.
  • Nutrition Division, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico.
  • Department of Global Health and Population Harvard T.H. Chan School of Public Health Boston Massachusetts USA.
  • Department of Medicine University of Michigan Ann Arbor Michigan USA.

ORCID-Profile: Daniel Ramírez-García, Jerónimo Perezalonso-Espinosa, Carlos A Fermín-Martínez, Juan Pablo Díaz-Sánchez, César Daniel Paz-Cabrera, Arsenio Vargas-Vázquez, Miriam Teresa López-Teros, Jennifer Manne-Ghoeler, Goodarz Danaei, Jacqueline A Seiglie, Omar Yaxmehen Bello-Chavolla

Zitieren

APA

Ramírez-García, D., Perezalonso-Espinosa, J., Méndez-Labra, P. N., Fermín-Martínez, C. A., Díaz-Sánchez, J. P., Paz-Cabrera, C. D., Vargas-Vázquez, A., López-Teros, M. T., Flood, D., Manne-Ghoeler, J., Antonio-Villa, N. E., Danaei, G., Seiglie, J. A., & Bello-Chavolla, O. Y. (2026). Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044366

Vancouver

Ramírez-García D, Perezalonso-Espinosa J, Méndez-Labra PN, Fermín-Martínez CA, Díaz-Sánchez JP, Paz-Cabrera CD, et al. Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044366

BibTeX
@article{RamrezGarca2026,
  author = {Ramírez-García, Daniel and Perezalonso-Espinosa, Jerónimo and Méndez-Labra, Padme Nailea and Fermín-Martínez, Carlos A and Díaz-Sánchez, Juan Pablo and Paz-Cabrera, César Daniel and Vargas-Vázquez, Arsenio and López-Teros, Miriam Teresa and Flood, David and Manne-Ghoeler, Jennifer and Antonio-Villa, Neftali Eduardo and Danaei, Goodarz and Seiglie, Jacqueline A and Bello-Chavolla, Omar Yaxmehen},
  title = {Cardiovascular Risk Management in Adults With Diagnosed Diabetes in Mexico From 2016 to 2023: A Retrospective Analysis of Nationally Representative Surveys},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.044366}
}
Kostenlos starten →